The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies

ConclusionOur meta-analysis of high-quality multicenter RCTs suggests that full-dose anticoagulation with heparin or low molecular weight heparin reduces all-cause mortality in hospitalized non-critically ill COVID-19 patients.Study registration: PROSPERO, review no. CRD42022348993.Graphical Abstract
Source: Lung - Category: Respiratory Medicine Source Type: research